“Mad Money” host Jim Cramer spoke with both CVS Health president and CEO Larry Merlo and Target chairman and CEO Brian Cornell to get some additional insight into the deal between the two companies.
While online sales of allergy products may still be relatively low, thousands of consumers are making these purchases online — and many millions more are using the Web to learn about products and decide which brands to purchase.
Target plans to sell its pharmacy business to CVS Health for $1.9 billion and rebrand its nearly 1,700 prescription departments as CVS/pharmacy in a blockbuster deal that stunned the healthcare world.
Target said the plan to double the amount of its share buyback authorization represents a continued focus on returning cash to shareholders.
Target chief Brian Cornell talks to CNBC's Jim Cramer about what the company is doing to turn its business around. What else does Target have up its sleeve and how will it keep the momentum going?
A new vitamin player generated $1 million in its first two weeks on the shelf. And that's just at Target.
Target executives said they are “pleased” with its first quarter, particularly its signature categories.
Target’s leadership has been quite vocal about its desire to reinvent its food business to focus on healthier options and, according to a Wall Street Journal report.
Target will sell Target Commercial Interiors, a subsidiary that provides office furnishings and related services for business and commercial clients.
Psi Bands expands distribution to 1,000 Target locations.